Total Shoulder Arthroplasty
21
1
2
12
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 29/100
9.5%
2 terminated out of 21 trials
85.7%
-0.8% vs benchmark
48%
10 trials in Phase 3/4
50%
6 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (21)
Effects on Postoperative Pain of Liposomal Bupivacaine in Interscalene Blocks for Total Shoulder Arthroplasty Patients
Addition of a Pectoserratus Block to Interscalene Block in Patients Undergoing Total Shoulder Replacement
ZYNRELEF vs Continuous Catheter for Pain Management Following Shoulder Arthroplasty
Subscapularis-Sparing Total Shoulder Arthroplasty
Postoperative Pain Control in Total Shoulder Arthroplasty
Exparel for Total Shoulder Arthroplasty
Surgiphor Us in TSA
Total Shoulder Arthroplasty Preoperative Pain Threshold and Association With Postoperative Opioid Consumption
Ultrasound After Total Shoulder Arthroplasty
Comparison of Analgesic Efficacy Between of Interscalene Block With Liposomal Bupivacaine With Bupivacaine and Dexamethasone
Diagnostic Accuracy of Synovial Biopsy for Implant-Related Shoulder Infections
A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE.
LIBERATE - LIposomal Bupivacaine vERsus Adjuncts in Total shouldErs
Post Surgical Pain in Arthroscopic Shoulder
A Retrospective Review of FloSeal Use in Total Shoulder Arthroplasty
Patient Specific Instruments Versus Standard Surgical Instruments
Posterior Approach to Total Shoulder Arthroplasty
Glenosphere Size and Scapular Notch in RSA, Prospective Randomized Study
Pain Management After Total Shoulder Arthroplasty
Analgesia After Total Shoulder Arthroplasty